(MedPage Today) -- DENVER -- Patients with advanced kidney cancer treated with immune checkpoint inhibitors (ICIs) lived longer if they consumed a high-fiber diet, a small prospective study showed.
While past studies have explored how cancer patients' financial health influenced their risk of mortality, new research digs in deeper by zeroing in on objective data: credit scores.
The Federal Government of Nigeria and the National Cancer Intervention Fund (NCIF) have strategised on ways to mobilise fund for treatment of cancer patients across the 36 states of Nigeria.
(MedPage Today) -- DENVER -- A majority of patients with non-locally treated brain metastases from kidney cancer remained free of metastatic progression for at least 6 months when treated with cabozantinib (Cabometyx), a small prospective…
(MedPage Today) -- DENVER -- A discussion about patient-centered issues in kidney cancer management focused considerable attention on the controversial antiparasitic ivermectin, which was not even on the program at the International Kidney…
The study sought to answer questions about how breast cancer risk differs by type of hormonal contraceptive. Doctors say the results won't change how they counsel patients.
People in England with a learning disability have a higher risk of cancer, especially before age 50 , according to a study by researchers from The University of Manchester and The ChristieNHS Foundation Trust .
Melanoma remains one of the hardest skin cancers to diagnose because it often mimics harmless moles or lesions. While most artificial intelligence (AI) tools rely on dermoscopic images alone, they often overlook crucial patient information…
Patient-derived xenograft (PDX) models are emerging as a transformative tool in colorectal cancer (CRC) research, offering unparalleled insights into tumor biology, drug resistance, and personalized treatment approaches.
(MedPage Today) -- Patients with colon cancer and a history of treatment with GLP-1 receptor agonists for obesity had a 5-year mortality rate that was less than half the rate for patients who didn't take these drugs, according to a large…
New results from a multicenter clinical trial show that combining immunotherapy drugs nivolumab and ipilimumab significantly improves treatment response in patients with advanced and difficult-to-treat cancers. The trial results have been…